cro.directory
← Compare landing

Cardiomedex vs Certis Oncology Solutions, Inc.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cardiomedex/certisoncology

CategoryCardiomedexCertis Oncology Solutions, Inc.
Listed sitecrocro
SummaryCardiomedex is a preclinical CRO specialized in cardiovascular disease models, offering in vivo efficacy studies, ex vivo functional exploration, and in vitro assays for drug candidates targeting heart failure, myocardial infarction, hypertension, and cardiometabolic complications.Certis Oncology Solutions provides translational oncology research services including custom cancer model development, in vitro/ex vivo pharmacology, in vivo pharmacology, imaging analysis, and immuno-oncology studies powered by CertisAI predictive technology.
Services
  • Cardiovascular & Metabolic Specialty Services
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Translational Research
  • Oncology Specialty Services
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • Clinical Imaging Core Lab
  • Immunology & Inflammation Services
Modalities
  • Small Molecule
Data not yet provided.
Indications
  • Cardiovascular
  • Metabolic
  • Oncology
Locations
  • Headquarters, Toulouse, France
  • Headquarters, San Diego, CA, USA
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.